Page 160 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oxford COVID-19 vaccine gets approval for emergency use in India

Oxford COVID-19 vaccine gets approval for emergency use in India
mid-day.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mid-day.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomExpert committee of the drug regulatorIndian council of medical researchSerum institute of indiaExpert committeeHealth ministrySerum instituteDrugs controller generalPune based serum instituteBharat biotechIndian councilMedical researchSubject expert committeeDrug regulatorCentral drug standard control organization

COVID-19 expert panel recommends Serum Institute s Covishield for emergency usage; DCGI to take final call

COVID-19 expert panel recommends Serum Institute s Covishield for emergency usage; DCGI to take final call
firstpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from firstpost.com Daily Mail and Mail on Sunday newspapers.

United kingdomVinod paulPrakash kumar singhCentral drugs standard control organisationRegulatory agencyRegulatory affairs at serum institute of indiaExpert committeeSerum institute of indiaOxford universitySubject expert committeeSerum instituteIndia todayDrug controller generalPune based serum instituteAdditional directorRegulatory affairs

Oxford-AstraZeneca s Covishield vaccine cleared by expert panel

Oxford-AstraZeneca s Covishield vaccine cleared by expert panel By IANS | Published on Fri, Jan 1 2021 18:03 IST | 0 Views SII to conduct trials of Covishield vaccine. (Photo: Aritra /IANS). Image Source: IANS News New Delhi, Jan 1 : In a step closer towards India approving its first coronavirus vaccine, the Subject Expert Committee of the Central Drug Standard Control Organisation on Friday recommended emergency use of Oxford-AstraZeneca s Covishield vaccine. The application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval. The expert panel had convened a meeting on Friday afternoon to take a call on the emergency use authorisation sought by the Serum Institute of India, which is Covishield s manufacturer, and Bharat Biotech for their coronavirus vaccine candidates.

United statesNew delhiOxford astrazeneca covishieldUnion territoriesSerum instituteIndian council of medical researchSerum institute of indiaHealth ministrySubject expert committeeCentral drug standard control organisationDrugs controller generalBharat biotechPune based serum instituteIndian councilMedical researchNew year

COVID-19 panel recommends SII s Covishield for emergency use; new cases remain under 30,000 for 19th day

COVID-19 panel recommends SII s Covishield for emergency use; new cases remain under 30,000 for 19th day The daily new coronavirus infections in India remained below 30,000 for the 19th consecutive day on Friday, taking the total caseload to 1,02,86,709 FP Staff January 01, 2021 19:13:24 IST Representational image. The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting emergency use authorisation for the Oxford COVID-19 vaccine Covishield , being manufactured by Serum Institute of India, reports said. According to a report in CNBC-TV18, the recommendation comes with certain conditions, but didn t elaborate. India Today said the Drug Controller General of India will take a final call on whether or not to approve the vaccine for emergency usage authorisation.

United kingdomTamil naduUttar pradeshSuresh kumarMahanagara palikePinarayi vijayanUnion health ministryCentral drugs standard control organisationRegulatory agencyTechnology for educationHome departmentEducation departmentExpert committeeOxford universitySerum institute of indiaSubject expert committee

CDSCO panel recommends grant of permission for restricted emergency use of Oxford Covid-19 vaccine

An expert panel on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended grant of permission for restricted emergency use of Oxford Covid-19 vaccine Covishield in India, subject to certain regulatory provisions, official sources said. As for Bharat Biotech, the Subject Expert Committee (SEC) on Covid-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated. The SEC, which earlier had sought additional safety, immunogenicity and efficacy data from SII and Bharat Biotech, deliberated on their applications seeking emergency use authorisation (EUA) for their shots on Wednesday, and met again on Friday to review the matter.

United kingdomPrakash kumar singhOxford covidCentral drugs standard control organisationRegulatory agencyRegulatory affairs at serum institute of indiaExpert committeeOxford universitySerum institute of indiaBharat biotechSubject expert committeePune based serum instituteAdditional directorRegulatory affairsSerum instituteDrugs controller general